Insights from 2023 ASCO® Annual Meeting


 

ASCO® 2023 Insights: "Results From the Randomized Phase 3 OLIGO Study - High Dose Alkylating Chemo for Pts With Oligometastatic BC Harboring HRD"

118 views
June 16, 2023
Comments 0
Login to view comments. Click here to Login